Literature DB >> 17034027

Estimated glomerular filtration rate in sickle cell anemia is associated with polymorphisms of bone morphogenetic protein receptor 1B.

Vikki G Nolan1, Qianli Ma, Herbert T Cohen, Adeboye Adewoye, Anne C Rybicki, Clinton Baldwin, Rhea N Mahabir, Erica P Homan, Diego F Wyszynski, Mary E Fabry, Ronald L Nagel, Lindsay A Farrer, Martin H Steinberg.   

Abstract

Renal disease is common in sickle cell anemia. In this exploratory work, we used data from a longitudinal study of the natural history of sickle cell disease to examine the hypothesis that polymorphisms (SNPs) in selected candidate genes are associated with glomerular filtration rate (GFR). DNA samples and clinical and laboratory data were available for 1,140 patients with sickle cell anemia. GFR was estimated using the Cockcroft-Gault and Schwartz formulas for adults and children, respectively. We examined approximately 175 haplotype tagging (ht) SNPs in about 70 genes of the TGFbeta/BMP pathway for their association with GFR using linear regression. Four SNPs in BMPR1B, a bone morphogenetic protein (BMP) receptor gene, yielded statistically significant associations (P values ranging from 0.015 to 0.046). Three haplotypes in this gene were also associated with GFR. The TGF-beta/BMP pathway has been associated with the development of diabetic nephropathy, which has some features in common with sickle cell nephropathy. Our results suggest that, as with other subphenotypes of sickle cell disease, renal function may be genetically modulated. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17034027     DOI: 10.1002/ajh.20800

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  15 in total

1.  Biomarkers for early detection of sickle nephropathy.

Authors:  Nambirajan Sundaram; Michael Bennett; Jamie Wilhelm; Mi-Ok Kim; George Atweh; Prasad Devarajan; Punam Malik
Journal:  Am J Hematol       Date:  2011-05-31       Impact factor: 10.047

Review 2.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 3.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

Review 4.  Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection.

Authors:  Marcus G Pezzolesi; Jan Skupien; Josyf C Mychaleckyj; James H Warram; Andrzej S Krolewski
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

5.  Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia.

Authors:  Russell E Ware; Jenny M Despotovic; Nicole A Mortier; Jonathan M Flanagan; Jin He; Matthew P Smeltzer; Amy C Kimble; Banu Aygun; Song Wu; Thad Howard; Alex Sparreboom
Journal:  Blood       Date:  2011-08-29       Impact factor: 22.113

6.  MYH9 and APOL1 are both associated with sickle cell disease nephropathy.

Authors:  Allison E Ashley-Koch; Emmanuel C Okocha; Melanie E Garrett; Karen Soldano; Laura M De Castro; Jude C Jonassaint; Eugene P Orringer; James R Eckman; Marilyn J Telen
Journal:  Br J Haematol       Date:  2011-09-13       Impact factor: 6.998

Review 7.  The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait.

Authors:  Rakhi P Naik; Vimal K Derebail
Journal:  Expert Rev Hematol       Date:  2017-10-30       Impact factor: 2.929

8.  Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

Authors:  A Driss; K O Asare; J M Hibbert; B E Gee; T V Adamkiewicz; J K Stiles
Journal:  Genomics Insights       Date:  2009-07-30

Review 9.  Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.

Authors:  Alawi Habara; Martin H Steinberg
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-01

10.  Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease.

Authors:  Allison E Ashley-Koch; Laine Elliott; Melanie E Kail; Laura M De Castro; Jude Jonassaint; Terry L Jackson; Jennifer Price; Kenneth I Ataga; Marc C Levesque; J Brice Weinberg; Eugene P Orringer; Ann Collins; Jeffery M Vance; Marilyn J Telen
Journal:  Blood       Date:  2008-01-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.